Hikma Pharmaceuticals PLC 2024 Annual Report with Sustainability Disclosures
Company: Hikma Pharmaceuticals PLC
Sector: Manufacturing
Country: United Kingdom
Year: 2024
Type: Annual Report with Sustainability Disclosures
Pages: 111
The report describes a strong 2024 financial performance, with Group revenue of $3,127 million and core revenue of $3,156m. It reports market-based Scope 1 and 2 emissions of 123,307 tonnes of CO2e, a 15% decrease from the 2020 base year, and a 25% reduction target by 2030. The company also completed a comprehensive double materiality assessment and reports 9,500 employees and $4.1m of donated medicines.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.